India: Gilead Grants Generic HIV Drug Licenses
September 25, 2006
On Friday, California-based Gilead Sciences announced it has signed eight non-exclusive licensing agreements to allow Indian generic drug companies to manufacture versions of its HIV drug Viread. Under the licenses, the companies -- Alkem Laboratories Ltd., Aurobindo Pharma Ltd., FCS Ltd., J.B. Chemicals & Pharmaceuticals Ltd., Matrix Laboratories Ltd., Medchem International, Ranbaxy Laboratories and Shasun Chemicals & Drugs Ltd. -- can produce tenofovir disoproxil fumarate and distribute it to 95 developing nations, including India. Last month, Gilead made similar arrangements with the Indian firms Emcure Pharmaceuticals Ltd., Hetero Drugs Ltd. and Strides Arcolab Ltd.
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.